ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 224,51
0,45%
Dow Jones
39 529,41
0,36%
DAX
18 762,95
0,45%
Brent Oil
83,745
-0,24%
Bitcoin
61 815,16
-1,96%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Vickers Vantage Corporation I (VCKA)

  7. Vickers Vantage Corporation I (VCKA) Actualités

VCKA

Vickers Vantage Corporat... (VCKA)

Vickers Vantage Corporation I
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:VCKA
DateHeureSourceTitreSymboleSociété
28/06/202312h15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:VCKAVickers Vantage Corporation I
22/06/202312h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VCKAVickers Vantage Corporation I
20/06/202312h02Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:VCKAVickers Vantage Corporation I
12/05/202322h02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VCKAVickers Vantage Corporation I
09/05/202312h01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:VCKAVickers Vantage Corporation I
20/04/202312h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VCKAVickers Vantage Corporation I
10/04/202323h16Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:VCKAVickers Vantage Corporation I
05/04/202323h28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:VCKAVickers Vantage Corporation I
14/03/202321h03Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:VCKAVickers Vantage Corporation I
07/03/202323h13Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VCKAVickers Vantage Corporation I
03/03/202315h11Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:VCKAVickers Vantage Corporation I
13/02/202319h53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VCKAVickers Vantage Corporation I
23/01/202322h12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VCKAVickers Vantage Corporation I
29/11/202217h44Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:VCKAVickers Vantage Corporation I
10/11/202222h00Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:VCKAVickers Vantage Corporation I
31/10/202214h00GlobeNewswire Inc.Scilex Holding Company (“Scilex”), a Sorrento Company (nearly 100% or over 99.9% majority-owned subsidiary of Sorrento Therapeutics, Inc.) (Nasdaq: SRNE, “Sorrento”), and Vickers Vantage Corp. I Announce Effectiveness of Registration Statement on FNASDAQ:VCKAVickers Vantage Corporation I
27/10/202221h33Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:VCKAVickers Vantage Corporation I
18/10/202223h07Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:VCKAVickers Vantage Corporation I
31/08/202205h21GlobeNewswire Inc.Scilex Holding Company, a Sorrento Company, Announces That the FDA Has Granted Fast Track Designation for SP-103 (Lidocaine Topical System) 5.4%, Next Generation Triple Strength Formulation of ZTlido®, for the Treatment of Acute Low Back Pain (LBP)NASDAQ:VCKAVickers Vantage Corporation I
17/08/202215h00GlobeNewswire Inc.Scilex Holding Company, a Sorrento Company, Announces Exclusive Product Distribution Agreement with CH Trading Group LLC to Expand Commercialization of ZTlido® across certain designated territories including Middle East and North AfricaNASDAQ:VCKAVickers Vantage Corporation I
16/08/202215h00GlobeNewswire Inc.Scilex Holding Company, a Sorrento Company, Announces Expanding Coverage to 30 Million Lives And Will Continue To Work To Access An Additional 20 Million Lives With One Of The Largest National Pharmacy Benefit Managers (PBMs) For ZTlido® (lidocaine topicaNASDAQ:VCKAVickers Vantage Corporation I
07/07/202215h30GlobeNewswire Inc.Scilex Holding Company, a Sorrento Company, Has Entered A Term Sheet to Acquire Ancora Medical Inc.NASDAQ:VCKAVickers Vantage Corporation I
05/07/202220h04GlobeNewswire Inc.Scilex Holding Company, a Sorrento Company, announces that the Honorable Tommy G. Thompson has joined the Scilex Board of DirectorsNASDAQ:VCKAVickers Vantage Corporation I
14/06/202216h33GlobeNewswire Inc.Scilex Holding Company, a Sorrento Company, enters into an agreement for an exclusive license with ROMEG Therapeutics, LLC, for the right to commercialize Gloperba®, an FDA-approved prophylactic treatment for painful gout flares in adults, in the US.NASDAQ:VCKAVickers Vantage Corporation I
07/06/202214h45Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:VCKAVickers Vantage Corporation I
03/06/202215h00GlobeNewswire Inc.Scilex Holding Company, a Sorrento Company, Announces Pre-Emptive Repurchase of $41.4 Million of its Senior Secured NotesNASDAQ:VCKAVickers Vantage Corporation I
18/05/202215h30GlobeNewswire Inc.Scilex, a Sorrento Company, Announces Initiation of a Phase 2 Study to Evaluate the Safety and Efficacy of SP-103 in Subjects with Acute Low Back PainNASDAQ:VCKAVickers Vantage Corporation I
16/05/202215h00GlobeNewswire Inc.Scilex Holding Company, a Sorrento Company, and Vickers Vantage Corp. I announced today the filing of a Registration Statement on Form S-4 with the Securities and Exchange Commission relating to the previously announced proposed business combination betweeNASDAQ:VCKAVickers Vantage Corporation I
11/05/202215h00GlobeNewswire Inc.Scilex, a Sorrento Company, Highlights Safety Data From Phase 1 Trial of SP-104, a Proprietary Low Dose Naltrexone for FibromyalgiaNASDAQ:VCKAVickers Vantage Corporation I
06/05/202202h05GlobeNewswire Inc.Scilex, a Sorrento Company, Announces Pivotal Phase 3 SP-102 (SEMDEXA™) Data Presentation At The American Society Of Interventional Pain (ASIPP) 2022 Annual MeetingNASDAQ:VCKAVickers Vantage Corporation I
 Showing the most relevant articles for your search:NASDAQ:VCKA

Dernières Valeurs Consultées

COIN
ETHUSD
Ethereum
NASDAQ
MSFT
Microsoft
EU
CS
Axa
EU
EN
Bouygues
NASDAQ
AMZN
Amazon.com
EU
AI
Air Liquide
NYSE
NKE
Nike
EU
ACA
Credit Agricole
EU
ML
Michelin
EU
GLE
Societe Generale
EU
RI
Pernod Ricard
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés